Rational Drug Design : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2018.
|
| Edición: | 1st ed. 2018. |
| Colección: | Methods in Molecular Biology,
1824 |
| Materias: |
Tabla de Contenidos:
- Conformational Properties of hIAPP22-29 (NFGAILSS) and Rational Drug Design
- Electronic and Electrostatic Approaches to the Development of Peptide-based Inhibitors of Amylin Aggregation
- In Silico Drug Design: Applications of non-peptide mimetics towards the immunotherapy of multiple sclerosis
- Binding Moiety Mapping by Saturation Transfer Difference NMR
- Protein Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection
- Rational Drug Design using Integrative Structural Biology
- Enalos+Knime Nodes: New Cheminformatics Tools for Drug Discovery
- Bioguided Design of Trypanosomicidal Compounds: A Successful Strategy in Drug Discovery
- A Hybrid Virtual Screening Protocol Based on Binding Mode Similarity
- Single Step Determination of Unlabelled Compound Kinetics Using a Competition Association Binding Method Employing Time-resolved FRET
- Dynamic Undocking: A Novel Method for Structure-based Drug Discovery
- The impact of Lipophilicity in Drug Discovery – Rapid Measurements by Means of Reversed Phase HPLC
- Exploring Polypharmacology in Drug Design
- Development of Nuclear Receptor Modulators
- In silico Screening of Compound Libraries using a Consensus of Orthogonal Methodologies
- Insights in Organometallic Synthesis of Various Adamantane Derivatives with Sigma Receptor (σR) Binding Affinity and Antiproliferative / Anticancer Activity
- Supervised Molecular Dynamics (SuMD) Approaches in Drug Design
- Lead Identification through the Synergistic Action of Biomolecular NMR and in Silico Methodologies
- The use of Dynamic Pharmacophore in Computer Aided Hit Discovery: A Case Study
- Rational Design of MAGL inhibitors
- Application of Virtual Screening Approaches for the Identification of Small Molecule Inhibitors of the methyllysine Reader Protein Spindlin1
- Designing Natural Product Hybrids Bearing Triple Antiplatelet Profile and Enhanced Human Plasma Stability
- Pharmacophore Generation and 3D-QSAR Model Development using PHASE
- Design of Drugs by Filtering through ADMET, Physicochemical, and Ligand-Target Flexibility Properties
- Reactions in NMR tubes as Key Weapon in Rational Drug Design
- Application of Multiscale Simulations Tools on GPCRs. An Example with Angiotensin-II type 1 receptor
- Angiotensin II Type 1 Receptor Homology Models: A Comparison between In Silico and the Crystal Structures. .